• Patient-Derived Gastric Cancer Assembloids Advance Drug Test

  2026-07-17

  This study introduces a robust assembloid model that integrates patient-matched gastric cancer organoids and stromal cell subpopulations, better recapitulating the tumor microenvironment than traditional organoid models. The innovation significantly improves our understanding of drug response variability and resistance mechanisms, supporting more precise preclinical testing and personalized therapy development.

• WNT5a/GSK3/β-catenin Axis Regulates Muscle FAP Adipogenesis

  2026-07-17

  This study identifies the WNT5a/GSK3/β-catenin axis as a critical regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs). The findings highlight potential strategies for limiting intramuscular fat infiltration in myopathies by targeting Wnt/β-catenin signaling.

• Vasopressin Analogues: Lypressin Acetate in Modern Research

  2026-07-16

  The reference review by Glavaš et al. offers a comprehensive analysis of vasopressin analogues, highlighting lypressin acetate’s distinct pharmacological features and its emerging relevance in both endocrine and antiviral research. The paper consolidates evidence on receptor selectivity, clinical benchmarks, and translational challenges, making it a key resource for researchers working with peptide therapeutics.

• Sulfur Supply Modulates Soybean Nodule Senescence via NO Dyn

  2026-07-16

  This study uncovers sulfur’s pivotal regulatory role in delaying soybean nodule senescence, demonstrating that sulfur transport into the symbiosome preserves glutathione and enables efficient scavenging of reactive nitrogen species. These findings offer new mechanistic insight into nutrient signaling in symbiotic nitrogen fixation and suggest practical strategies to enhance legume productivity and sustainability.

• Cdk5 Inhibition Reverses Neuronal Ferroptosis via AMPK Pathw

  2026-07-15

  This study demonstrates that downregulating Cdk5 in hippocampal neurons reduces ferroptosis after ischemic stroke by modulating the AMPK pathway and microglial polarization. The mechanistic insights advance understanding of neuroprotective strategies and provide a framework for future research into regulated cell death in stroke models.

• Practical Use of Okadaic Acid (A4540) as a Phosphatase 1 Inh

  2026-07-15

  Okadaic acid is a potent, marine-derived inhibitor of protein phosphatases PP1 and PP2A, enabling precise control of phosphorylation-dependent pathways in cell signaling and apoptosis assays. It should be applied in workflows requiring selective phosphatase inhibition but avoided in protocols where off-target effects or solvent interference could compromise results.

• Alda 1: Advanced ALDH2 Activator for Cardioprotection Resear

  2026-07-14

  Alda 1 from APExBIO stands out as a potent ALDH2 activator, uniquely effective in both wild-type and ALDH2*2 variant models. Its application in ischemia and radiation research is transforming protocols, offering powerful advantages for cardioprotection and beyond.

• Trelagliptin succinate Enhances Insulin Sensitivity via PI3K

  2026-07-14

  This study elucidates how trelagliptin succinate (SYR-472 succinate), a selective DPP-4 inhibitor, directly improves insulin resistance in adipocytes by modulating the PI3K/Akt/GLUT4 pathway. The results clarify key mechanisms underlying its glucose-lowering effects and provide a strong foundation for its use in diabetes mellitus research.

• Estradiol–Autophagy Axis Protects Organs During Perimenopaus

  2026-07-13

  This study reveals that declining serum estradiol during perimenopause is strongly linked to increased risks of metabolic and cardiovascular diseases. By integrating human cohort data, network pharmacology, and mouse models, the research uncovers how estrogen receptor–dependent autophagy mediates organ protection and offers mechanistic insights relevant for precision hormone therapies.

• Strategic Targeting of AP-1: T-5224 in Translational Inflamm

  2026-07-13

  T-5224, a selective C-Fos/AP-1 inhibitor from APExBIO, is reshaping the landscape of inflammation and oncology research. This article offers mechanistic insight into AP-1’s pivotal role in disease progression, presents recent evidence for T-5224’s action in cancer and arthritis models, and provides practical guidance for integrating this tool into translational workflows. By connecting AP-1 activity with ferroptosis and the PI3K/AKT pathway, we chart a strategic path for researchers pursuing next-generation therapies and precision disease modeling.

• BAPTA Calcium Chelator: Precision Tools for Decoding Apoptos

  2026-07-12

  Explore how BAPTA, a potent calcium chelator, enables unprecedented precision in dissecting calcium signaling and apoptosis, particularly in complex toxicant co-exposure models. This article provides unique, protocol-ready insights that go beyond existing guides.

• T-5224: AP-1 Inhibition for Arthritis and Myeloma Research

  2026-07-10

  T-5224 (C-Fos/AP-1 inhibitor) enables precise modulation of inflammatory and osteoclastogenic gene expression, supporting robust workflows in both arthritis and oncology research. Recent advances reveal its unique capacity to induce ferroptosis in multiple myeloma via the PI3K/AKT pathway, expanding its experimental impact beyond classic inflammation models.

• Calpain Inhibitor I, ALLN: Technical Use in Apoptosis & Inju

  2026-07-09

  Calpain Inhibitor I, ALLN (A2602) is designed to provide potent, selective inhibition of calpain and cathepsin proteases for research applications in apoptosis assays and ischemia-reperfusion injury models. It is intended for use in controlled laboratory workflows that require precise modulation of proteolytic activity but is not suitable for diagnostic, therapeutic, or aqueous solution-based protocols.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride in Endothelial Inju

  2026-07-09

  Leverage 5-(N,N-dimethyl)-Amiloride hydrochloride for precise inhibition of Na+/H+ exchange and advanced control of intracellular pH in endothelial injury and sepsis models. This guide details experimental workflows, troubleshooting, and the translational impact of targeting pH homeostasis in vascular research.

• Ultra Fast LC-MS/MS for Simultaneous Cefazedone and Etimicin

  2026-07-08

  This study presents a validated ultra fast LC-MS/MS method for the simultaneous quantification of cefazedone and etimicin in beagle dog plasma, enabling robust pharmacokinetic analysis of combination antibiotic therapy. The approach addresses longstanding analytical challenges and ensures precise measurement, supporting optimal therapeutic strategies for Gram-positive and Gram-negative infections.

451 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page